Exploring Under the Surface: Yielding Higher Value From Life Science Transactions
October 28, 2008
While many now acknowledge the importance of intellectual property (IP) due diligence in evaluating investments, strategic partnerships, licensing, and M&A deals, those issues that lie below the surface are often overlooked, decreasing company value and opening the door for future litigation. A due diligence plan should delve deeper, consider the full life cycle of the company, and incorporate strategies for managing IP, regulatory, and business issues.
Life science CEOs, entrepreneurs, venture capitalists, managers, and in-house counsel recently attended Exploring Under the Surface: Yielding Higher Value From Life Science Transactions. For questions or further details, please contact Zulaikha Rahim at zrahim@foley.com.
People
Related Insights
June 5, 2025
Health Care Law Today
GLP-1 Compounded Medications Targeted by Connecticut Attorney General
On May 21, 2025, the Connecticut Office of the Attorney General released a statement and sent letters to Connecticut weight loss clinics, med spas, medical practices and other businesses regarding allegedly or potentially unfair and deceptive conduct relating to compounded GLP-1 medications.
June 4, 2025
Energy Current
Nuclear’s Comeback: What Renewables Professionals Should Know
The clean energy transition isn’t a zero-sum game – it’s a team effort. And one player is stepping back into the spotlight with renewed…
June 4, 2025
Foley Ignite
M&A Disputes Set to Rise in Latin America: How Savvy Investors Are Protecting Themselves
As deal activity shows signs of rebounding in 2025, investors are bracing for an increase in M&A-related disputes globally, and Latin…